Gastrointestinal artificial intelligence

GI Genius™ intelligent endoscopy module

<p>The GI Genius™ intelligent endoscopy module is the first-to-market, computer-aided polyp detection system powered by artificial intelligence.</p>

Features

Harness the power of AI-assisted colonoscopy with the GI Genius™ system.

GI Genius™ intelligent endoscopy module helps the physician detect colorectal polyps of various sizes, shapes, and morphologies.4

Powered by AI, Medtronic is delivering disruptive innovation that empowers you to optimally care for your patients. GI Genius™ intelligent endoscopy module has a 99.7% sensitivity rate and less than 1% false positives.5

Join us in the fight against colorectal cancer.

90%

of patients with colon cancer will beat it when caught early.6


Increase adenoma detection rate (ADR), to decrease cancer risks.

Your goal is to reduce your patients' risk of colorectal cancer by identifying potentially harmful lesions.

Colonoscopy can be preventative against the development of colorectal cancer by early detection and resection of neoplastic lesions. However, the procedure is highly operator dependent and detection rates can vary greatly.3

Demonstrated in a recent study, the GI Genius™ intelligent endoscopy module can help enhance ADR. Reducing your patients’ risk of undetected polyps3 without changing your procedure — and without changing your withdrawal time.2

Each 1% increase in adenoma detection rate (ADR) is associated with a

3%

decrease if interval cancer risks.2

See what a colorectal cancer expert has to say.

The GI Genius™ intelligent endoscopy module offers a transformative solution — to address the challenges of preventing colorectal cancer. By harnessing deep learning algorithms and real-time data, we empower physicians to detect and treat colorectal polyps through enhanced visualization.

Professor Alessandro Repici describes his clinical experience with the GI Genius™ intelligent endoscopy module.


Discover Genius Academy

A virtual educational platform with relevant resources on artificial intelligence (AI) in GI care.
 


 

Colorectal cancer is treatable and beatable, with early diagnosis.

Despite evidence that screening reduces colorectal cancer (CRC) incidence and mortality, about 40% of age-eligible adults are not up to date on CRC screenings.7


“Go and screen. It’s the smartest thing anyone could do — eliminate a problem before it occurs.”

Patrick, colon cancer survivor

Ordering information

Item number Description Units per box
CB1708-EU GI Genius™ intelligent endoscopy module 1

Related links

Capsule Endoscopy System Tech Support Promo Box

Technical support

Get technical support for all gastrointestinal and hepatology products.

Email us
Phone
: 1-800-448-3644, option 3

Get support

Capsule Endoscopy System Reimbursement Promo Box

Reimbursement

Find reimbursement guides that detail the full range of reimbursement services we offer.

Email us
Phone
: 1-888-389-5200, option 1

View guides

  1. Corley DA, Jenson CD, Marks AR JR, et al. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014;370:2539–2541.
  2. Repici A, Badalamenti M, Maselli R, et al. Efficacy of real-time computer-aided detection of colorectal neoplasia in a randomized trial. Gastroenterology. 2020;159:512–520.e7.
  3. Corley DA, Jensen CD, Marks AR, et al. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014;370:1298–1306.
  4. Recipi A, Badalamenti M, Maselli R, et al. Artificial intelligence for colorectal polyp detection: high accuracy and detection anticipation with CB-17-08 performance. Gastrointestinal Endoscopy. June 2019.

  1. Hassan C, Wallace MB, Sharma P, et al. New artificial intelligence system: first validation study versus experienced endoscopists for colorectal polyp detection. Gut. 2020; 69:799–800.
  2. Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet (London, England). 2014;383(9927):1490–1502.
  3. Muthukrishnan M, Arnold LD, James AS. Patients’ self-reported barriers to colon cancer screening in federally qualified health center settings. Prev Med Rep. 2019;15;15:100896.